Nickenig G - Search Results

1

Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation.

Lassègue B, Alexander RW, Nickenig G, Clark M, Murphy TJ, Griendling KK. Lassègue B, et al. Among authors: nickenig g. Mol Pharmacol. 1995 Oct;48(4):601-9. Mol Pharmacol. 1995. PMID: 7476884

2

Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression.

Nickenig G, Murphy TJ. Nickenig G, et al. Mol Pharmacol. 1994 Oct;46(4):653-9. Mol Pharmacol. 1994. PMID: 7969043

3

Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells.

Nickenig G, Murphy TJ. Nickenig G, et al. Mol Pharmacol. 1996 Oct;50(4):743-51. Mol Pharmacol. 1996. PMID: 8863818

4

The vascular smooth muscle type I angiotensin II receptor mRNA is destabilized by cyclic AMP-elevating agents.

Wang X, Nickenig G, Murphy TJ. Wang X, et al. Among authors: nickenig g. Mol Pharmacol. 1997 Nov;52(5):781-7. doi: 10.1124/mol.52.5.781. Mol Pharmacol. 1997. PMID: 9351968

5

Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system.

Warnholtz A, Nickenig G, Schulz E, Macharzina R, Bräsen JH, Skatchkov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, Böhm M, Meinertz T, Münzel T. Warnholtz A, et al. Among authors: nickenig g. Circulation. 1999 Apr 20;99(15):2027-33. doi: 10.1161/01.cir.99.15.2027. Circulation. 1999. PMID: 10209008

6

Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.

Wassmann S, Laufs U, Bäumer AT, Müller K, Konkol C, Sauer H, Böhm M, Nickenig G. Wassmann S, et al. Among authors: nickenig g. Mol Pharmacol. 2001 Mar;59(3):646-54. doi: 10.1124/mol.59.3.646. Mol Pharmacol. 2001. PMID: 11179461

7

Regulation of angiotensin AT1 receptor gene expression during cell growth of vascular smooth muscle cells.

Nickenig G, Sachinidis A, Ko Y, Vetter H. Nickenig G, et al. Eur J Pharmacol. 1996 Feb 22;297(3):307-12. doi: 10.1016/0014-2999(95)00771-7. Eur J Pharmacol. 1996. PMID: 8666064

8

Angiotensin type-1 (AT1) receptor gene expression in primarily cultured human arterial umbilical endothelial cells.

Ko Y, Glodny B, Stier S, Totzke G, Nickenig G, Düsing R, Sachinidis A, Vetter H. Ko Y, et al. Among authors: nickenig g. Biochem Pharmacol. 1997 Feb 7;53(3):417-21. doi: 10.1016/s0006-2952(96)00691-0. Biochem Pharmacol. 1997. PMID: 9065746

9

Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.

Nickenig G, Laufs U, Schnabel P, Knorr A, Paul M, Böhm MP. Nickenig G, et al. Br J Pharmacol. 1997 May;121(1):134-40. doi: 10.1038/sj.bjp.0701088. Br J Pharmacol. 1997. PMID: 9146897 Free PMC article.

10

Negative feedback regulation of reactive oxygen species on AT1 receptor gene expression.

Nickenig G, Strehlow K, Bäumer AT, Baudler S, Wassmann S, Sauer H, Böhm M. Nickenig G, et al. Br J Pharmacol. 2000 Oct;131(4):795-803. doi: 10.1038/sj.bjp.0703623. Br J Pharmacol. 2000. PMID: 11030730 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

880 results

Search Page

Filters